Journal of Cancer Research and Therapeutics,
Journal Year:
2023,
Volume and Issue:
19(Suppl 1), P. S404 - S408
Published: Jan. 1, 2023
Though
as
per
literature
cancer
is
also
consider
an
associated
risk
factor
for
morbidity
and
mortality
covid
infection
but
practically
most
of
the
patients
showed
no
symptoms
with
less
in
second
wave
pandemic.
So
this
cross
sectional
comparative
analysis
study
was
designed
to
see
prevalence
sero-conversion
SARS
-coV
IgG
infected
compare
antibodies
level
between
healthy
persons.Covid-19
antibody
screening
recovered
well
persons
done
department
Transfusion
Medicine.IgG
COVID-19
detected
using
microtiter
plate
whole-cell
antigen
coating,
in-house
validated
kit
by
NIV
ICMR3.
Prevalence
noted
down
both
groups
compared.There
more
infectivity
rate
wave.
Case
fatality
much
lesser
compared
1st
patients.
In
maximum
seroconversion
seen
younger
group
i.e.
21-30
yrs.
age,
contrast
finding
general
population,
where
minimum
age
group.
It
observed
that
sero
conversion
population
patients,
difference
non-significant.Though
normal
person,
none
them
any
moderate
or
severe
inspite
being
a
severity
covid.
larger
are
required
comment
on
statistical
conclusion.
European Respiratory Review,
Journal Year:
2021,
Volume and Issue:
30(162), P. 210138 - 210138
Published: Oct. 20, 2021
Coronavirus
disease
2019
(COVID-19)
pneumonia
is
an
evolving
disease.
We
will
focus
on
the
development
of
its
pathophysiologic
characteristics
over
time,
and
how
these
time-related
changes
determine
modifications
in
treatment.
In
emergency
department:
peculiar
characteristic
coexistence,
a
significant
fraction
patients,
severe
hypoxaemia,
near-normal
lung
computed
tomography
imaging,
gas
volume
respiratory
mechanics.
Despite
high
drive,
dyspnoea
rate
are
often
normal.
The
underlying
mechanism
primarily
altered
perfusion.
anatomical
prerequisites
for
PEEP
(positive
end-expiratory
pressure)
to
work
(lung
oedema,
atelectasis,
therefore
recruitability)
lacking.
high-dependency
unit:
starts
worsen
either
because
natural
evolution
or
additional
patient
self-inflicted
injury
(P-SILI).
Oedema
atelectasis
may
develop,
increasing
recruitability.
Noninvasive
supports
indicated
if
they
result
reversal
hypoxaemia
decreased
inspiratory
effort.
Otherwise,
mechanical
ventilation
should
be
considered
avert
P-SILI.
intensive
care
primary
advance
unresolved
COVID-19
progressive
shift
from
oedema
less
reversible
structural
alterations
fibrosis.
These
later
associated
with
notable
impairment
mechanics,
increased
arterial
carbon
dioxide
tension
(
P
aCO
2
),
recruitability
lack
response
prone
positioning.
The Lancet Global Health,
Journal Year:
2021,
Volume and Issue:
9(9), P. e1216 - e1225
Published: July 9, 2021
The
first
wave
of
COVID-19
in
South
Africa
peaked
July,
2020,
and
a
larger
second
January,
2021,
which
the
SARS-CoV-2
501Y.V2
(Beta)
lineage
predominated.
We
aimed
to
compare
in-hospital
mortality
other
patient
characteristics
between
waves.In
this
prospective
cohort
study,
we
analysed
data
from
DATCOV
national
active
surveillance
system
for
admissions
hospital
March
5,
27,
2021.
contained
all
hospitals
that
have
admitted
with
COVID-19.
used
incidence
risk
admission
determined
cutoff
dates
define
five
periods:
pre-wave
1,
post-wave
2,
2.
compared
patients
who
were
1
factors
accounting
period
using
random-effect
multivariable
logistic
regression.Peak
rates
cases,
admissions,
deaths
exceeded
wave:
240·4
cases
per
100
000
people
vs
136·0
people;
27·9
16·1
deaths,
8·3
3·6
people.
weekly
average
growth
rate
was
20%
43%
2
(ratio
1·19,
95%
CI
1·18-1·20).
Compared
wave,
individuals
more
likely
be
age
40-64
years
(adjusted
odds
ratio
[aOR]
1·22,
1·14-1·31),
older
than
65
(aOR
1·38,
1·25-1·52),
younger
40
years;
Mixed
race
1·21,
1·06-1·38)
White
race;
public
sector
1·65,
1·41-1·92);
less
Black
0·53,
0·47-0·60)
Indian
0·77,
0·66-0·91),
White;
comorbid
condition
0·60,
0·55-0·67).
For
analysis,
after
adjusting
there
31%
increased
1·31,
1·28-1·35).
In-hospital
case-fatality
17·7%
weeks
low
(<3500
admissions)
26·9%
very
high
(>8000
admissions;
aOR
1·24,
1·17-1·32).In
Africa,
associated
higher
COVID-19,
rapid
increase
hospital,
mortality.
Although
some
can
explained
by
being
individuals,
sector,
health
pressure,
residual
could
related
new
Beta
lineage.DATCOV
as
is
funded
National
Institute
Communicable
Diseases
African
Government.
BMJ Open,
Journal Year:
2021,
Volume and Issue:
11(6), P. e047007 - e047007
Published: June 1, 2021
Objectives
To
investigate
the
risk
factors
contributing
to
severity
on
admission.
Additionally,
of
worst
and
fatality
were
studied.
Moreover,
compared
based
three
points:
early
severity,
fatality.
Design
An
observational
cohort
study
using
data
entered
in
a
Japan
nationwide
COVID-19
inpatient
registry,
COVIREGI-JP.
Setting
As
28
September
2020,
10480
cases
from
802
facilities
have
been
registered.
Participating
cover
wide
range
hospitals
where
patients
with
are
admitted
Japan.
Participants
who
had
positive
test
result
any
applicable
SARS-CoV-2
diagnostic
tests
participating
healthcare
facilities.
A
total
3829
identified
16
January
31
May
which
3376
included
this
study.
Primary
secondary
outcome
measures
was
severe
or
nonsevere
admission,
determined
by
requirement
mechanical
ventilation
oxygen
therapy,
SpO2
respiratory
rate.
Secondary
during
hospitalisation,
judged
and/orinvasive
ventilation/extracorporeal
membrane
oxygenation.
Results
Risk
for
admission
older
age,
men,
cardiovascular
disease,
chronic
diabetes,
obesity
hypertension.
Cerebrovascular
liver
renal
disease
dialysis,
solid
tumour
hyperlipidaemia
did
not
influence
admission;
however,
it
influenced
severity.
Fatality
rates
obesity,
hypertension
relatively
lower.
Conclusions
This
segregated
comorbidities
influencing
death.
It
is
possible
that
consistent
may
be
propelled
different
factors.
Specifically,
while
hypertension,
major
effect
their
impact
mild
Japanese
population.
Some
studies
contradict
our
results;
therefore,
detailed
analyses,
considering
in-hospital
treatments,
needed
validation.
Trial
registration
number
UMIN000039873.
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045453
The Indian Journal of Medical Research,
Journal Year:
2021,
Volume and Issue:
153(5), P. 619 - 619
Published: Jan. 1, 2021
Background
&
objectives:
India
witnessed
a
massive
second
surge
of
COVID-19
cases
since
March
2021
after
period
decline
from
September
2020.
Data
collected
under
the
National
Clinical
Registry
for
(NCRC)
were
analysed
to
describe
differences
in
demographic
and
clinical
features
patients
recruited
during
these
two
successive
waves.
Methods:
The
NCRC,
launched
2020,
is
an
ongoing
multicentre
observational
initiative,
which
provided
platform
current
investigation.
Demographic,
clinical,
treatment
outcome
data
hospitalized,
confirmed
captured
electronic
portal
41
hospitals
across
India.
Patients
enrolled
1,
2020
January
31,
February
1
May
11,
constituted
participants
waves,
respectively.
Results:
As
on
2021,
18961
individuals
registry,
12059
6903
reflecting
in-patients
first
Mean
age
was
significantly
lower
wave
[48.7
(18.1)
yr
vs.
50.7
(18.0)
yr,
P<0.001]
with
higher
proportion
younger
group
intervals
<20,
20-39
yr.
Approximately
70
per
cent
admitted
≥
40
both
waves
pandemic.
males
slightly
as
compared
[4400
(63.7%)
7886
(65.4%),
P=0.02].
Commonest
presenting
symptom
fever
In
wave,
[2625
(48.6%)
4420
(42.8%),
P<0.003]
complained
shortness
breath,
developed
ARDS
[422(13%)
880
(7.9%),
P<0.001],
required
supplemental
oxygen
[1637
(50.3%)
4771
(42.7%),
mechanical
ventilation
[260
(15.9%)
530
(11.1%),
P<0.001].
Mortality
also
increased
[OR:
1.35
(95%
CI:
1.19,
1.52)]
all
groups
except
<20
Interpretation
conclusions:
different
presentation
than
demography,
lesser
comorbidities,
breathlessness
greater
frequency.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2021,
Volume and Issue:
unknown
Published: March 10, 2021
ABSTRACT
Introduction
South
Africa
experienced
its
first
wave
of
COVID-19
peaking
in
mid-July
2020
and
a
larger
second
January
2021,
which
the
SARS-CoV-2
501Y.V2
lineage
predominated.
We
aimed
to
compare
in-hospital
mortality
other
patient
characteristics
between
waves
COVID-19.
Methods
analysed
data
from
DATCOV
national
active
surveillance
system
for
hospitalisations.
defined
four
periods
using
incidence
risk
hospitalisation,
pre-wave
1,
2
2.
compared
hospitalised
cases
1
2,
factors
accounting
period
multivariable
logistic
regression.
Results
Peak
rates
cases,
admissions
deaths
exceeded
(138.1
versus
240.1;
16.7
28.9;
3.3
7.1
respectively
per
100,000
persons).
The
weekly
average
increase
hospitalisation
was
22%
28%
[ratio
growth
rate
two
one:
1.04,
95%
CI
1.04-1.05].
On
analysis,
after
adjusting
hospital
admissions,
there
20%
increased
(adjusted
OR
1.2,
1.2-1.3).
In-hospital
case
fatality-risk
(CFR)
weeks
peak
occupancy,
17.9%
low
occupancy
(<3,500
admissions)
29.6%
very
high
(>12,500
1.5,
1.4-1.5).
Compared
wave,
individuals
were
more
likely
be
older,
40-64
years
[OR
1.1,
1.0-1.1]
≥65
1.1-1.1]
<40
years;
admitted
public
sector
2.2,
1.7-2.8];
less
have
comorbidities
0.5,
0.5-0.5].
Conclusions
In
Africa,
associated
with
higher
rapid
hospitalisations,
mortality.
While
some
this
is
explained
by
increasing
pressure
on
health
system,
residual
patients
beyond
this,
could
related
new
501Y.V2.
RESEARCH
IN
CONTEXT
Evidence
before
study
Most
countries
reported
numbers
but
lower
case-fatality
(CFR),
part
due
therapeutic
interventions,
testing
better
prepared
systems.
peaked
variant
concern,
New
variants
been
shown
transmissible
United
Kingdom,
people
infected
B.1.1.7
infection
non-B.1.1.7
viruses.
There
are
currently
limited
severity
Added
value
comparing
revealed
that
wave.
Our
also
describes
demographic
shift
quantifies
impact
overwhelmed
capacity
Implications
all
available
evidence
suggest
(501Y.V2)
may
during
should
interpreted
caution
however
as
our
analysis
based
comparison
proxy
dominant
we
did
not
individual-level
lineage.
Individual
level
studies
outcomes
without
sequencing
needed.
To
prevent
potential
third
require
combination
strategies
slow
transmission
SARS-CoV-2,
spread
out
epidemic,
would
being
breached.
Scientific Reports,
Journal Year:
2021,
Volume and Issue:
11(1)
Published: Oct. 21, 2021
Abstract
In
Europe,
multiple
waves
of
infections
with
SARS-CoV-2
(COVID-19)
have
been
observed.
Here,
we
investigated
whether
common
patterns
cytokines
could
be
detected
in
individuals
mild
and
severe
forms
COVID-19
two
pandemic
waves,
machine
learning
approach
useful
to
identify
the
best
predictors.
An
increasing
trend
was
observed
patients
or
severe/critical
symptoms
COVID-19,
compared
healthy
volunteers.
Linear
Discriminant
Analysis
(LDA)
clearly
recognized
three
groups
based
on
cytokine
patterns.
Classification
Regression
Tree
(CART)
further
indicated
that
IL-6
discriminated
controls
patients,
whilst
IL-8
defined
disease
severity.
During
second
wave
pandemics,
a
less
intense
storm
observed,
as
first.
most
robust
predictor
infection
moderate
from
controls,
regardless
epidemic
peak
curve.
Thus,
serum
provide
biomarkers
for
diagnosis
prognosis.
Further
definition
individual
may
allow
envision
novel
therapeutic
options
pave
way
set
up
innovative
diagnostic
tools.
BMC Infectious Diseases,
Journal Year:
2022,
Volume and Issue:
22(1)
Published: May 3, 2022
Only
a
few
studies
have
performed
comprehensive
comparisons
between
hospitalized
patients
from
different
waves
of
COVID-19.
Thus,
we
aimed
to
compare
the
clinical
characteristics
and
laboratory
data
admitted
western
part
Denmark
during
first
second
COVID-19
in
2020.
Furthermore,
identify
risk
factors
for
critical
disease
describe
available
information
on
sources
infection.We
retrospective
study
medical
records
311
consecutive
patients,
157
wave
1
154
2.
The
period
March
7
June
30,
2020,
was
considered
1,
July
1st
December
31,
Data
are
presented
as
total
population,
comparison
2,
with
without
(nonsurvivors
intensive
care
unit
(ICU)).Patients
experienced
more
severe
course
than
Admissions
ICU
fatal
were
significantly
higher
among
compared
percentage
infected
at
hospital
decreased
2
whereas
home
We
found
no
significant
differences
sociodemographics,
lifestyle
information,
or
However,
age,
sex,
smoking
status,
comorbidities,
fever,
dyspnea
identified
disease.
observed
increased
levels
C-reactive
protein
creatinine,
lower
hemoglobin
disease.At
admission,
severely
ill
outcomes
worse
1.
confirmed
previously
In
addition,
that
most
infections
acquired
home.
Cureus,
Journal Year:
2023,
Volume and Issue:
unknown
Published: April 12, 2023
Introduction
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
continuously
evolving,
and
many
mutant
variants
of
the
virus
are
circulating
in
world.
Recurrent
waves
COVID-19
have
caused
enormous
mortality
all
across
globe.
Considering
novelty
virus,
it
becomes
crucial
for
healthcare
experts
policymakers
to
understand
demographic
clinical
attributes
inpatient
deaths
first
second
COVID-19.
Methods
This
hospital
record-based
comparative
study
was
conducted
at
a
tertiary
care
Uttarakhand,
India.
included
RT
PCR-positive
patients
admitted
during
wave,
from
1st
April
2020
31st
January
2021,
wave
March
2021
30th
June
2021.
Comparisons
were
made
with
respect
demographic,
clinical,
laboratory
parameters,
course
stay.
Results
exhibited
11.34%
more
casualties
number
being
424
475
waves,
respectively.
A
male
preponderance
evident
both
significant
differences
(p=0.004).
There
no
difference
age
between
two
(p=0.809).
significantly
different
comorbidities
hypertension
(p=0.003)
coronary
artery
disease
(p=0.014).
manifestations
demonstrating
cough
(p=0.000),
sore
throat
(p=0.002),
altered
mental
status
headache
(p=0.025),
loss
taste
smell
(p=0.001),
tachypnea
(p=0.000).
lab
parameters
lymphopenia
elevated
aspartate
aminotransferase
(p=0.004),
leukocytosis
(p=0.008),
thrombocytopenia
During
terms
intensive
unit
stay,
need
non-invasive
ventilation
inotrope
support
higher.
complications
manifesting
form
distress
sepsis
observed
wave.
discerned
median
duration
stay
Conclusion
Despite
shorter
duration,
culminated
deaths.
demonstrated
that
most
baseline
characteristics
attributed
common
COVID-19,
including
complications,
stays.
unpredictable
nature
calls
instituting
well-planned
surveillance
mechanism
place
identify
surge
cases
earliest
possible
time
prompt
response,
along
developing
infrastructure
capacity
manage
complications.